This test is most useful if any of these apply to you.
Molds quietly release chemical byproducts called mycotoxins into food, dust, and damp indoor air. Your body absorbs a share of what you breathe or eat, processes it, and sends the remainder out in your urine.
This panel reads that urine for 29 different mold toxins at once. It is an exposure-mapping tool, used mostly in research and functional medicine settings, that shows what recently reached you rather than proving any specific illness.
People are almost never exposed to just one mold toxin. Biomonitoring studies find that co-exposure is the rule: in a Swedish adult study, more than one toxin was found in 69% of people, and in one Southern Italy study every volunteer carried two or more. A broad panel is designed to catch that mixture, which no single-toxin test can show.
The panel groups into several exposure stories. The aflatoxin markers track toxins from Aspergillus molds on grains and nuts, the family with the clearest human health link. The kidney-associated group, mainly ochratoxin A and citrinin, reflects stored-grain, coffee, and wine molds. The Fusarium group, including deoxynivalenol, zearalenone, and the fumonisins, tracks cereal and corn toxins, one of which mimics estrogen.
A separate cluster targets water-damaged buildings. The macrocyclic trichothecenes (satratoxins, roridins, and verrucarins), along with chaetoglobosin A, come from Stachybotrys and related damp-loving molds. In laboratory studies these toxins block the machinery cells use to build proteins, which is why they draw interest, but the human evidence tying a urine level to illness remains associative and unsettled. Toxicology reviews also note that inhaled doses in moldy indoor spaces are generally far below the levels shown to cause harm.
The value of the panel is in the pattern, not any one number. A few toxins together can matter even when each alone looks modest. In a Chinese adult study, samples containing both deoxynivalenol and zearalenone were flagged for a possible combined hormone-disrupting effect that neither toxin triggered on its own.
| Pattern | What It May Suggest |
|---|---|
| Several Fusarium markers together (deoxynivalenol, zearalenone, fumonisins) | A cereal- and corn-heavy dietary exposure, the most common source pattern |
| Aflatoxin markers plus ochratoxin A | Added exposure from stored or poorly kept grains, nuts, coffee, or wine |
| Water-damage toxins (satratoxins, roridins, verrucarins) present | An exploratory clue toward damp-building exposure that needs an environmental check, not a diagnosis |
| Metabolites present (aflatoxin M1, dihydrocitrinone) | The parent toxin was truly absorbed and processed, a stronger sign than a parent toxin alone |
Treat a positive result as a prompt to investigate, not a verdict. Because diet is the dominant source for most of these toxins, the first step is a review of recent food, especially grains, corn, nuts, coffee, and dried fruit. If water-damage toxins show up, an inspection of your home or workplace for moisture and visible mold is the logical next move.
Serial tracking is where this panel earns its place. Levels swing widely over time: when European adults gave two full-day urine collections a month apart, concentrations of almost every toxin changed by more than half, and only about 7% of people tested positive for the same toxin groups both times. A single result is a snapshot, so repeat testing under similar diet and hydration, ideally on first-morning urine, gives a more honest read on whether an exposure is persistent. Bring results to a clinician who can weigh them alongside your symptoms, diet, and any liver or kidney markers.
Several limits affect the whole panel at once. Urine reflects recent exposure, so results shift with what you ate in the prior day or two and with how dilute your urine is, which is why labs correct for concentration. Ochratoxin A, for instance, binds tightly to blood proteins and has a long stay in the body, so blood often captures its long-term exposure better than urine does, leaving a urine-only panel less complete for it.
The deepest limit is interpretation. Commercial urine mold panels reviewed in the United States were not validated by regulators, used in-house reference ranges, and in some cases counted any detectable amount as positive. Detecting a toxin proves exposure happened; it does not prove that mold caused a given symptom or pinpoint the building it came from. Standardized clinical cutoffs for these toxins do not yet exist.
Mycotoxins II is best interpreted alongside these tests.